Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells.

Celano M, Maggisano V, Lepore SM, Sponziello M, Pecce V, Verrienti A, Durante C, Maranghi M, Lucia P, Bulotta S, Damante G, Russo D.

Int J Endocrinol. 2019 Feb 14;2019:5031696. doi: 10.1155/2019/5031696. eCollection 2019.

2.

Secoiridoids of olive and derivatives as potential coadjuvant drugs in cancer: A critical analysis of experimental studies.

Celano M, Maggisano V, Lepore SM, Russo D, Bulotta S.

Pharmacol Res. 2019 Apr;142:77-86. doi: 10.1016/j.phrs.2019.01.045. Epub 2019 Feb 14. Review.

PMID:
30772463
3.

Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells.

Maggisano V, Celano M, Lepore SM, Sponziello M, Rosignolo F, Pecce V, Verrienti A, Baldan F, Mio C, Allegri L, Maranghi M, Falcone R, Damante G, Russo D, Bulotta S.

Endocrine. 2019 Mar;63(3):545-553. doi: 10.1007/s12020-018-01836-2. Epub 2019 Jan 19.

PMID:
30661164
4.

Reading Cancer: Chromatin Readers as Druggable Targets for Cancer Treatment.

Mio C, Bulotta S, Russo D, Damante G.

Cancers (Basel). 2019 Jan 9;11(1). pii: E61. doi: 10.3390/cancers11010061. Review.

5.

Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells.

Lepore SM, Maggisano V, Lombardo GE, Maiuolo J, Mollace V, Bulotta S, Russo D, Celano M.

Endocr Metab Immune Disord Drug Targets. 2019;19(1):59-66. doi: 10.2174/1871530318666180928153241.

PMID:
30264682
6.

Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice.

Lombardo GE, Lepore SM, Morittu VM, Arcidiacono B, Colica C, Procopio A, Maggisano V, Bulotta S, Costa N, Mignogna C, Britti D, Brunetti A, Russo D, Celano M.

Front Endocrinol (Lausanne). 2018 Mar 19;9:116. doi: 10.3389/fendo.2018.00116. eCollection 2018.

7.

Anti-hTERT siRNA-Loaded Nanoparticles Block the Growth of Anaplastic Thyroid Cancer Xenograft.

Lombardo GE, Maggisano V, Celano M, Cosco D, Mignogna C, Baldan F, Lepore SM, Allegri L, Moretti S, Durante C, Damante G, Fresta M, Russo D, Bulotta S, Puxeddu E.

Mol Cancer Ther. 2018 Jun;17(6):1187-1195. doi: 10.1158/1535-7163.MCT-17-0559. Epub 2018 Mar 21.

8.

MicroRNAs as Biomarkers in Thyroid Carcinoma.

Celano M, Rosignolo F, Maggisano V, Pecce V, Iannone M, Russo D, Bulotta S.

Int J Genomics. 2017;2017:6496570. doi: 10.1155/2017/6496570. Epub 2017 Sep 6. Review.

9.

Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer.

Celano M, Mio C, Sponziello M, Verrienti A, Bulotta S, Durante C, Damante G, Russo D.

Mol Cell Endocrinol. 2018 Jul 5;469:38-47. doi: 10.1016/j.mce.2017.05.036. Epub 2017 Jun 2. Review.

PMID:
28579118
10.

Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells.

Maggisano V, Celano M, Lombardo GE, Lepore SM, Sponziello M, Rosignolo F, Verrienti A, Baldan F, Puxeddu E, Durante C, Filetti S, Damante G, Russo D, Bulotta S.

Mol Cell Endocrinol. 2017 Jun 15;448:34-40. doi: 10.1016/j.mce.2017.03.007. Epub 2017 Mar 10.

PMID:
28288903
11.

Expression of YAP1 in aggressive thyroid cancer.

Celano M, Mignogna C, Rosignolo F, Sponziello M, Iannone M, Lepore SM, Lombardo GE, Maggisano V, Verrienti A, Bulotta S, Durante C, Di Loreto C, Damante G, Russo D.

Endocrine. 2018 Jan;59(1):209-212. doi: 10.1007/s12020-017-1240-6. Epub 2017 Jan 24. No abstract available.

PMID:
28120182
12.

Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells.

Sponziello M, Rosignolo F, Celano M, Maggisano V, Pecce V, De Rose RF, Lombardo GE, Durante C, Filetti S, Damante G, Russo D, Bulotta S.

Mol Cell Endocrinol. 2016 Aug 15;431:123-32. doi: 10.1016/j.mce.2016.05.007. Epub 2016 May 10.

PMID:
27173027
13.

Oral Administration of Oleuropein and Its Semisynthetic Peracetylated Derivative Prevents Hepatic Steatosis, Hyperinsulinemia, and Weight Gain in Mice Fed with High Fat Cafeteria Diet.

Lepore SM, Morittu VM, Celano M, Trimboli F, Oliverio M, Procopio A, Di Loreto C, Damante G, Britti D, Bulotta S, Russo D.

Int J Endocrinol. 2015;2015:431453. doi: 10.1155/2015/431453. Epub 2015 Dec 22.

14.

Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine.

Bulotta S, Celano M, Costante G, Russo D.

Endocrine. 2016 May;52(2):214-21. doi: 10.1007/s12020-015-0830-4. Epub 2015 Dec 21. Review.

PMID:
26690657
15.

Flavonoid Fraction of Citrus reticulata Juice Reduces Proliferation and Migration of Anaplastic Thyroid Carcinoma Cells.

Celano M, Maggisano V, De Rose RF, Bulotta S, Maiuolo J, Navarra M, Russo D.

Nutr Cancer. 2015;67(7):1183-90. doi: 10.1080/01635581.2015.1073760. Epub 2015 Sep 12.

PMID:
26365817
16.

PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells.

Sponziello M, Verrienti A, Rosignolo F, De Rose RF, Pecce V, Maggisano V, Durante C, Bulotta S, Damante G, Giacomelli L, Di Gioia CR, Filetti S, Russo D, Celano M.

Endocrine. 2015 Nov;50(2):434-41. doi: 10.1007/s12020-015-0586-x. Epub 2015 Apr 3.

PMID:
25837309
17.

Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases.

Bulotta S, Celano M, Lepore SM, Montalcini T, Pujia A, Russo D.

J Transl Med. 2014 Aug 3;12:219. doi: 10.1186/s12967-014-0219-9. Review.

18.

Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer.

Micali S, Bulotta S, Puppin C, Territo A, Navarra M, Bianchi G, Damante G, Filetti S, Russo D.

BMC Cancer. 2014 Apr 30;14:303. doi: 10.1186/1471-2407-14-303. Review.

19.

Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes.

Cosco D, Federico C, Maiuolo J, Bulotta S, Molinaro R, Paolino D, Tassone P, Fresta M.

Int J Nanomedicine. 2014 May 15;9:2359-72. doi: 10.2147/IJN.S58362. eCollection 2014.

20.

Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.

D'Agostino M, Sponziello M, Puppin C, Celano M, Maggisano V, Baldan F, Biffoni M, Bulotta S, Durante C, Filetti S, Damante G, Russo D.

J Mol Endocrinol. 2014 Jan 30;52(2):121-31. doi: 10.1530/JME-13-0160. Print 2014 Apr.

PMID:
24353283

Supplemental Content

Loading ...
Support Center